Etrinabdione (VCE-004.8), a B55α activator, promotes angiogenesis and arteriogenesis in critical limb ischemia

Abstract Background Vasculogenic therapies explored for the treatment of peripheral artery disease (PAD) have encountered minimal success in clinical trials. Addressing this, B55α, an isoform of protein phosphatase 2A (PP2A), emerges as pivotal in vessel remodeling through activation of hypoxia-indu...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Adela García-Martín, María E. Prados, Isabel Lastres-Cubillo, Francisco J. Ponce-Diaz, Laura Cerero, Martin Garrido-Rodríguez, Carmen Navarrete, Rafael Pineda, Ana B. Rodríguez, Ignacio Muñoz, Javier Moya, Antonella Medeot, José A. Moreno, Antonio Chacón, José García-Revillo, Eduardo Muñoz
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-11-01
Sarja:	Journal of Translational Medicine
Aiheet:	Etrinabdione VCE-004.8 PPA2/B55α HIF-1α Sirtuin 1 eNOS
Linkit:	https://doi.org/10.1186/s12967-024-05748-w
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!